Clinical Trials Directory

Trials / Completed

CompletedNCT06074224

Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
114 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Accepted

Summary

The investigators are interested in measuring the influence of addressing sleep in the orthopedic setting. This includes assessing patient experience measures (satisfaction with the visit, perceived empathy, communication effectiveness) as well as greater engagement in their healthcare (patient activation). The investigators will also see what factors might be associated with sleep disturbance and if addressing sleep leads to an intervention such as cognitive behavioral therapy.

Detailed description

All adult (18+ years old) new patients seeing a musculoskeletal specialist will be invited to enroll. For the purposes of this trial, The investigators will include people with lesser degrees of sleep disturbance including anyone with a score greater than 3. For people that are enrolled in the trial, the researcher will record the PSQI score and enter at the first page of survey filled out by the patient after meeting. P The patients in the intervention group will include those for whom their clinician was given their sleep questionnaire result before the visit. The control group will include patients whose clinicians do not view the results, simulating usual care. Patients in both groups will fill out a survey entailing demographics, sleep quality, JSPPPE.

Conditions

Interventions

TypeNameDescription
OTHERSleep assessment scoreThe patients in the intervention group will include those for whom their clinician was given their sleep questionnaire result before the visit.
OTHERNo ScoreThe patients in the control group will include those for whom their clinician was not given their sleep questionnaire result before the visit.

Timeline

Start date
2022-02-01
Primary completion
2023-09-01
Completion
2023-12-01
First posted
2023-10-10
Last updated
2025-07-31

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06074224. Inclusion in this directory is not an endorsement.